Objective: Patients with schizophrenia treated with clozapine often gain weight. This study
evaluated the effects of dietary control and physical activity among obese inpatients with …

Objective: Obese patients with schizophrenia being treated with clozapine and non-
psychiatric obese are often assumed to share the same physiological changes in obesity …

Objective: The management of atypical antipsychotic-induced weight gain is a significant
challenge for people with mental illness. Fundamental research into energy metabolism in …

OBJECTIVE: Clozapine is associated with significant weight gain. However, it is still
debatable whether the majority of weight gain occurs in the early phase of treatment or if …

PURPOSE. This paper reviews risks, assessments, antipsychotic medication choices, and
lifestyle interventions for obesity in persons with schizophrenia. CONCLUSIONS …

OBJECTIVE: With the rate of obesity on the rise worldwide, individuals with schizophrenia
represent a particularly vulnerable population. The aim of this study was to assess the …

Background: Obesity is common in persons with schizophrenia. Besides its adverse health
effects, obesity reduces quality of life and contributes to the social stigma of schizophrenia …

Obesity is a serious medical problem that disproportionately affects people with severe
mental illness. Behavioral strategies aimed at lifestyle modification have proven effective for …

Background Recently, a relationship between obesity and schizophrenia has been reported.
Although fat-mass and fat free mass have been shown to be more predictive of health risk …

Objective To review recent advances in the epidemiology, pathobiology, and management
of weight gain and obesity in patients with schizophrenia and to evaluate the extent to which …